Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 5/20 | 0.41 |
| ▸ | NOS1 | P29475 | 6/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PAH | P00439 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | PNP | P00491 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8798202 | 0.81 | HPRT1 (0.49) | HPRT1NOS1USP2CASP7HSD17B10 | |
| SCHEMBL2982031 | 0.81 | HPRT1 (0.53) | HPRT1NOS1USP2CASP7HSD17B10 | |
| SCHEMBL19464457 | 0.68 | HPRT1 (0.47) | HPRT1MAPTPNP | |
| SCHEMBL10870536 | 0.68 | HPRT1 (0.40) | HPRT1NOS1USP2CASP7HSD17B10 | |
| SCHEMBL2787048 | 0.67 | HPRT1 (0.50) | HPRT1NOS1USP2CASP7HSD17B10 | |
| SCHEMBL10871616 | 0.66 | TK1 (0.46) | HPRT1NOS1NOS3NOS2PNP | |
| SCHEMBL10873210 | 0.64 | HPRT1 (0.61) | HPRT1NOS1PNP | |
| SCHEMBL10872985 | 0.64 | HPRT1 (0.46) | HPRT1NOS1PNP | |
| SCHEMBL9544019 | 0.62 | PNP (0.36) | HSD17B10KDM4EALDH1A1GLAPMP22 | |
| SCHEMBL9545264 | 0.62 | XDH (0.35) | HSD17B10KDM4EALDH1A1GLAPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190317040-A1 | DEVICES AND METHODS FOR TARGET MOLECULE CHARACTERIZATION | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2019-10-17 | — | — | US | disclosed |
| US-10442771-B2 | Trans-base tunnel reader for sequencing | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2019-10-15 | — | — | US | disclosed |
| US-10330632-B2 | Devices and methods for target molecule characterization | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2019-06-25 | — | — | US | disclosed |
| US-20170204066-A1 | NANOPORE BASED SEQUENCER | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2017-07-20 | — | — | US | disclosed |
| US-9593372-B2 | Nanopore based sequencer | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2017-03-14 | — | — | US | disclosed |
| US-20170003245-A1 | DEVICES AND METHODS FOR TARGET MOLECULE CHARACTERIZATION | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2017-01-05 | — | — | US | disclosed |
| US-9395352-B2 | Devices and methods for target molecule characterization | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2016-07-19 | — | — | US | disclosed |
| US-20150211059-A1 | TRANS-BASE TUNNEL READER FOR SEQUENCING | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2015-07-30 | — | — | US | disclosed |
| US-8968540-B2 | Trans-base tunnel reader for sequencing | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2015-03-03 | — | — | US | disclosed |
| US-8961757-B2 | Nanopore and carbon nanotube based DNA sequencer | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2015-02-24 | — | — | US | disclosed |
| US-20130186757-A1 | Nanopore and Carbon Nanotube Based Dna Sequencer and A Serial Recognition Elements | ARIZONA BOARD OF REGENTS (US) | 2013-07-25 | — | — | US | disclosed |
| US-20110168562-A1 | Nanopore and Carbon Nanotube Based DNA Sequencer | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY | 2011-07-14 | — | — | US | disclosed |
| US-20110120868-A1 | Nanopore and Carbon Nanotube Based DNA Sequencer and a Serial Recognition Sequencer | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-05-26 | — | — | US | disclosed |
| WO-2010042514-A1 | NANOPORE AND CARBON NANOTUBE BASED DNA SEQUENCER AND A SERIAL RECOGNITION ELEMENTS | ARIZONA BOARD OF REGENTS (US) | 2010-04-15 | — | — | WO | disclosed |
| US-20100084276-A1 | Devices and Methods for Target Molecule Characterization | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-04-08 | — | — | US | disclosed |
| WO-2009117522-A2 | NANOPORE AND CARBON NANOTUBE BASED DNA SEQUENCER AND A SERIAL RECOGNITION SEQUENCER | REINHART, KEVIN (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009117517-A2 | NANOPORE AND CARBON NANOTUBE BASED DNA SEQUENCER | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2008124706-A9 | DEVICES AND METHODS FOR TARGET MOLECULE CHARACTERIZATION | UNIV ARIZONA STATE (US) | 2009-05-28 | — | — | WO | disclosed |
| WO-2008124706-A2 | DEVICES AND METHODS FOR TARGET MOLECULE CHARACTERIZATION | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2008-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204066-A1 | NANOPORE BASED SEQUENCER | DNMT3A, DNTT, TELO2 | HPRT1 1664/4885NOS1 2203/4885USP2 2908/4885 |
| US-10442771-B2 | Trans-base tunnel reader for sequencing | DNTT, TRDMT1, TELO2 | HPRT1 317/4885NOS1 2407/4885USP2 4350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.